Birth of offspring from spermatid or somatic cell by co-injection of PLCζ-cRNA.


Journal

Reproduction (Cambridge, England)
ISSN: 1741-7899
Titre abrégé: Reproduction
Pays: England
ID NLM: 100966036

Informations de publication

Date de publication:
08 2020
Historique:
received: 30 01 2020
accepted: 20 04 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 22 6 2021
Statut: ppublish

Résumé

Artificial oocyte activation is important for assisted reproductive technologies, such as fertilization with round spermatids (ROSI) or the production of cloned offspring by somatic cell nuclear transfer (SCNT). Recently, phospholipase Cζ (PLCζ)-cRNA was used to mimic the natural process of fertilization, but this method required the serial injection of PLCζ-cRNA and was found to cause damage to the manipulated oocytes. Here we tried to generate offspring derived from oocytes that were fertilized using round spermatid or somatic cell nuclear transfer with the co-injection of PLCζ-cRNA. After co-injecting round spermatids and 20 ng/µL of PLCζ-cRNA into the oocytes, most of them became activated, but the activation process was delayed by more than 1 h. With the co-injection method, the rate of blastocyst formation in ROSI embryos was higher (64%) compared with that of the serial injection method (55%). On another note, when SCNT was performed using the co-injection method, the cloned offspring were obtained with a higher success rate compared with the serial-injection method. However, in either ROSI or SCNT embryos, the birth rate of offspring via the co-injection method was similar to the Sr activation method. The epigenetic status of ROSI and SCNT zygotes that was examined showed no significant difference among all activation methods. The results indicated that although the PLCζ-cRNA co-injection method did not improve the production rate of offspring, this method simplified oocyte activation with less damage, and with accurate activation time in individual oocytes, it can be useful for the basic study of oocyte activation and development.

Identifiants

pubmed: 32585638
doi: 10.1530/REP-20-0054
pii: REP-20-0054
doi:
pii:

Substances chimiques

RNA, Complementary 0
Phosphoinositide Phospholipase C EC 3.1.4.11
Plcz1 protein, mouse EC 3.1.4.11

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

319-330

Auteurs

Naoki Hirose (N)

Advanced Biotechnology Center, University of Yamanashi, Yamanashi, Japan.

Sayaka Wakayama (S)

Faculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi, Japan.

Rei Inoue (R)

Advanced Biotechnology Center, University of Yamanashi, Yamanashi, Japan.

Junya Ito (J)

Laboratory of Animal Reproduction, Graduate School of Veterinary Science, Azabu University, Sagamihara, Japan.

Masatoshi Ooga (M)

Advanced Biotechnology Center, University of Yamanashi, Yamanashi, Japan.

Teruhiko Wakayama (T)

Advanced Biotechnology Center, University of Yamanashi, Yamanashi, Japan.
Faculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH